• C3.ai, Inc. reported past fourth-quarter revenue of US$51.6 million and a full-year total of US$250.27 million to 30 April 2026, alongside wider net losses and loss per share compared with the previous year.
• At the same time, C3.ai is extending its multi-year collaboration with Shell to deepen AI-driven reliability and root-cause analysis across Shell’s global operations, underscoring a contrast between customer adoption progress and internal execution challenges.
• We’ll now examine how C3.ai’s sharp revenue decline and workforce reduction, despite deeper Shell engagement, reshape the company’s investment narrative.

Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.

C3.ai Investment Narrative Recap

To own C3.ai today, you need to believe that its enterprise AI platform can convert high profile deployments into consistent, growing revenue despite deep losses and execution issues. The sharp revenue decline and heavier net losses keep the main near term catalyst squarely on fixing sales execution and restoring billings momentum, while the biggest risk remains persistent operating losses and negative free cash flow. The latest results reinforce rather than change that risk balance.

The most relevant recent development is Shell’s multi year extension of C3 AI Reliability across its global operations, including new AI agent based root cause analysis. This shows that large, existing customers can expand usage even as overall revenue falls, which matters for the thesis that deep reference accounts can eventually offset sales missteps. Whether more customers follow Shell’s path is critical to how the current restructuring ultimately plays out.

Yet against this backdrop of deeper Shell engagement, investors should also be aware that...

C3.ai's narrative projects $613.6 million revenue and $80.3 million earnings by 2028.

Uncover how C3.ai's forecasts yield a $14.67 fair value, a 36% upside to its current price.

Exploring Other Perspectives

Before this news, the most bearish analysts expected C3.ai’s revenue to shrink about 15.7% annually even as partnerships deepened, spotlighting how far views can diverge and why it is worth comparing several scenarios.

Explore 7 other fair value estimates on C3.ai - why the stock might be worth as much as 36% more than the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your C3.ai research is our analysis highlighting 2 important warning signs that could impact your investment decision.
• Our free C3.ai research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate C3.ai's overall financial health at a glance.

Searching For A Fresh Perspective?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Capitalize on the AI infrastructure supercycle with our selection of the 48 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• The future of work is here. Discover the 34 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.